Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
How do Golden Eagles select nest sites in a desert ecosystem?
This is part of a larger project that answers the question of why Golden Eagles choose their nest sites...
Genetic diversity across the Atlantic in a red seaweed
A major goal of ecology is to understand how organisms are distributed in nature. My research addresses...
